LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 266 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 4.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $249,000 | -79.2% | 3,425 | -61.2% | 0.00% | -75.0% |
| Q4 2018 | $1,198,000 | +385.0% | 8,825 | +880.6% | 0.01% | +700.0% |
| Q3 2018 | $247,000 | -32.7% | 900 | -87.0% | 0.00% | -66.7% |
| Q4 2014 | $367,000 | -34.9% | 6,900 | -42.5% | 0.00% | -40.0% |
| Q3 2014 | $564,000 | -50.6% | 12,000 | -30.2% | 0.01% | -37.5% |
| Q2 2014 | $1,141,000 | -68.9% | 17,200 | -65.2% | 0.01% | -70.4% |
| Q1 2014 | $3,668,000 | – | 49,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VILLERE ST DENIS J & CO LLC | 518,988 | $80,162,000 | 4.60% |
| Knott David M Jr | 75,000 | $11,585,000 | 3.93% |
| Orchard Capital Management, LLC | 68,596 | $10,595,000 | 3.11% |
| Chicago Capital, LLC | 436,456 | $67,415,000 | 2.51% |
| RICE HALL JAMES & ASSOCIATES, LLC | 347,699 | $53,706,000 | 1.91% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 85,990 | $13,282,000 | 1.46% |
| Smith, Graham & Co., Investment Advisors, LP | 87,392 | $13,499,000 | 1.34% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 44,754 | $6,913,000 | 1.12% |
| WOODSTOCK CORP | 68,666 | $10,606,000 | 1.11% |
| Stephens Investment Management Group LLC | 411,359 | $63,539,000 | 0.82% |